tiprankstipranks
Trending News
More News >
Nurix Therapeutics, Inc. (NRIX)
NASDAQ:NRIX
US Market

Nurix Therapeutics (NRIX) Income Statement

Compare
549 Followers

Nurix Therapeutics Income Statement

Last quarter (Q4 2025), Nurix Therapeutics's total revenue was $13.58M, an increase of 2.21% from the same quarter last year. In Q4, Nurix Therapeutics's net income was $-78.22M. See Nurix Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 83.98M$ 54.55M$ 76.99M$ 38.63M$ 29.75M
Gross Profit
$ 65.12M$ -167.08M$ -112.16M$ -145.87M$ -86.68M
Operating Expenses
$ 350.79M$ 45.94M$ 42.90M$ 38.00M$ 31.20M
Depreciation and Amortization
$ 18.86M$ 8.02M$ 6.13M$ 4.15M$ 1.99M
EBITDA
$ -244.84M$ -205.01M$ -148.93M$ -179.72M$ -115.90M
Operating Income
$ -285.67M$ -213.03M$ -155.06M$ -183.87M$ -117.89M
Other Income/Expenses
$ 21.97M$ 19.73M$ 11.12M$ 3.51M$ 823.00K
Pretax Income
$ -263.70M$ -193.30M$ -143.95M$ -180.36M$ -117.06M
Net Income
$ -264.46M$ -193.57M$ -143.95M$ -180.36M$ -117.19M
Per Share Metrics
Basic EPS
$ -3.05$ -2.88$ -2.65$ -3.71$ -2.73
Diluted EPS
$ -3.05$ -2.88$ -2.65$ -3.71$ -2.73
Weighted Average Shares Outstanding
86.67M 67.12M 54.34M 48.61M 42.90M
Weighted Average Shares Outstanding (Diluted)
86.67M 67.12M 54.34M 48.61M 42.90M
Currency in USD

Nurix Therapeutics Earnings and Revenue History